In the BioHarmony Drug Report Database

"Preview" Icon

Probucol

Lorelco (probucol) is a small molecule pharmaceutical. Probucol was first approved as Lorelco on 1982-01-01. It is used to treat coronary artery disease, hypercholesterolemia, and hyperlipoproteinemias in the USA. The pharmaceutical is active against phospholipid-transporting ATPase ABCA1.

 

Trade Name

 

Lorelco
 

Common Name

 

probucol
 

ChEMBL ID

 

CHEMBL608
 

Indication

 

coronary artery disease, hypercholesterolemia, hyperlipoproteinemias
 

Drug Class

 

Image (chem structure or protein)

Probucol structure rendering